Bill > HR6374

This bill aims to strengthen the supply chains for the Department of Defense (DoD), particularly in the area of pharmaceuticals. The key provisions include: 1. Requiring the Under Secretary of Defense for Acquisition and Sustainment to develop and issue guidance for risk management across all DoD supply chains, including identifying information gaps and vulnerabilities related to the DoD's reliance on foreign suppliers of drugs. 2. Directing the Director of the Defense Health Agency to develop and publish guidance for risk management specifically in the DoD's pharmaceutical supply chain, as well as establish a working group to assess risks and identify the most critical pharmaceuticals. 3. Requiring the Director of the Defense Logistics Agency to modify existing instructions to coordinate annual responsiveness testing of the agency's contingency contracts for pharmaceuticals and include the results in the agency's annual reports. The goal of the bill is to address the recommendations of the Inspector General of the Department of Defense regarding the mitigation of foreign suppliers in the DoD's pharmaceutical supply chain.

Military Affairs and Security

https://www.congress.gov/bill/117th-congress/house-bill/6374/all-info